Headquarters: Redwood City, California, United States
Trade prices
Volume:
Market Cap:606.22M
Prev closed:
Open:17.25
High:17.48
Low:16.47
52 week low:12.21
52 week high:22.22
Dividends:No Dividends
Next ER:May 8, 2023 After Market Closes
Top Stories (CHRS)
Company Profile
Coherus BioSciences, Inc. is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that may expand patient access to life-changing medicines in regulated markets worldwide. In 2018, the U.S. Food and Drug Administration approved Coherus? biosimilar UDENYCA® (pegfilgrastim-cbqv). Coherus is headquartered in the heart of California?s Silicon Valley and composed of a team of industry veterans with decades of experience pioneering biologics companies.
Talk about Coherus Biosciences Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
